| Application no. and date | 16721320.6 (espacenet) (Federated) (European Patent Register), 20160426 | | Patent/reg. no. and date | DK/EP 3288946, 20190821 | | Publication date | 20180307 | | Priority no. and date | US 201562153082 P, 20150427 | | EP pub. no. and date |
EP 3288946 20180307 | | Effective date | | | Applicant/owner | Arena Pharmaceuticals, Inc., 6154 Nancy Ridge Drive
San Diego, CA 92121, US | | Applicant ref. no. | V1911-025-DK | | Inventor | REN, Albert S., 4266 Corte De Sausalito
San Diego, California 92130, US,
ZHU, Xiuwen, 11367 Black Colt Lane
San Diego, California 92130, US,
SAGE, Carleton R., 1388 Peachwood Drive
Encinitas, California 92024, US,
SEMPLE, Graeme, 350 Nutmeg St. no. 307
San Diego, California 921303, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/407 (2006.01) , A61P 25/00 (2006.01) , C07D 487/06 (2006.01) | | Title | 5-HT2C-RECEPTORAGONISTER OG SAMMENSÆTNINGER OG ANVENDELSESFREMGANGSMÅDER | | Int. application no. | US2016029308 | | Int. publication no. | WO2016176177 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
